We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sandoz Drops Patent Challenge Against Cephalon's Provigil
Sandoz Drops Patent Challenge Against Cephalon's Provigil
May 17, 2005
Cephalon has dodged a patent challenge against its top-selling drug Provigil, which was recently targeted by an abbreviated new drug application (ANDA) filed by Sandoz.